A detailed history of Squarepoint Ops LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 39,705 shares of RGNX stock, worth $302,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,705
Previous 146,259 72.85%
Holding current value
$302,552
Previous $1.71 Million 75.69%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.49 - $14.39 $1.12 Million - $1.53 Million
-106,554 Reduced 72.85%
39,705 $416,000
Q2 2024

Aug 14, 2024

BUY
$11.51 - $21.53 $1.45 Million - $2.72 Million
126,249 Added 630.93%
146,259 $1.71 Million
Q1 2024

May 15, 2024

BUY
$12.17 - $24.61 $243,521 - $492,446
20,010 New
20,010 $421,000
Q4 2021

Feb 14, 2022

SELL
$30.19 - $40.28 $1.44 Million - $1.92 Million
-47,605 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$29.09 - $45.68 $595,268 - $934,749
20,463 Added 75.39%
47,605 $2 Million
Q2 2021

Aug 16, 2021

BUY
$32.46 - $40.48 $155,028 - $193,332
4,776 Added 21.35%
27,142 $1.05 Million
Q1 2021

May 17, 2021

BUY
$33.61 - $49.95 $172,318 - $256,093
5,127 Added 29.74%
22,366 $763,000
Q4 2020

Feb 16, 2021

SELL
$26.52 - $49.35 $751,629 - $1.4 Million
-28,342 Reduced 62.18%
17,239 $782,000
Q3 2020

Nov 16, 2020

BUY
$27.01 - $40.26 $578,689 - $862,570
21,425 Added 88.69%
45,581 $1.25 Million
Q2 2020

Aug 14, 2020

BUY
$27.75 - $43.44 $406,815 - $636,830
14,660 Added 154.38%
24,156 $890,000
Q1 2020

May 15, 2020

SELL
$21.5 - $54.2 $719,906 - $1.81 Million
-33,484 Reduced 77.91%
9,496 $307,000
Q4 2019

Feb 14, 2020

BUY
$34.54 - $44.87 $278,219 - $361,427
8,055 Added 23.06%
42,980 $1.76 Million
Q3 2019

Nov 14, 2019

BUY
$31.84 - $50.88 $1.11 Million - $1.78 Million
34,925 New
34,925 $1.24 Million
Q2 2019

Aug 14, 2019

SELL
$42.0 - $59.29 $2.54 Million - $3.59 Million
-60,537 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$40.82 - $62.45 $1.31 Million - $2.01 Million
32,192 Added 113.57%
60,537 $3.47 Million
Q4 2018

Feb 14, 2019

BUY
$39.11 - $75.15 $1.11 Million - $2.13 Million
28,345 New
28,345 $1.19 Million
Q3 2018

Nov 14, 2018

SELL
$65.0 - $82.15 $437,125 - $552,458
-6,725 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$27.2 - $74.35 $527,244 - $1.44 Million
-19,384 Reduced 74.24%
6,725 $483,000
Q1 2018

May 15, 2018

SELL
$24.05 - $37.5 $223,953 - $349,200
-9,312 Reduced 26.29%
26,109 $779,000
Q4 2017

Feb 14, 2018

BUY
$26.0 - $34.6 $920,946 - $1.23 Million
35,421
35,421 $1.18 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.